Evidence map›Paper›PMID 20072604›Full record

ArticlePLoS pathogens2010

Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.

Lucas R Hoffman, Anthony R Richardson, Laura S Houston, Hemantha D Kulasekara, Willm Martens-Habbena, Mikkel Klausen, Jane L Burns, David A Stahl, Daniel J Hassett, Ferric C Fang and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 134 citations in OpenAlex.

  1. Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. mBio · 2025
    Article
  8. Evolution of Resistant Mutants inMicroorganisms · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A rise in the frequency ofFrontiers in cellular and infection microbiology · 2023
    Article
  18. Article
  19. Article
  20. Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.Journal of the Pediatric Infectious Diseases Society · 2022
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lucas R HoffmanDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Anthony R Richardson
Laura S Houston
Hemantha D Kulasekara
Willm Martens-Habbena
Mikkel Klausen
Jane L Burns
David A Stahl
Daniel J Hassett
Ferric C Fang
Samuel I Miller
University of Washington · USUniversity of Cincinnati Medical Center · US

Funding

NITRIC OXIDE CYTOTOXICITY IN SALMONELLOSISR01AI039557 · NIAID · UNIVERSITY OF WASHINGTON · PI FANG, FERRIC C · 1997 to 2012
$4.1M
INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIST32AI055396 · NIAID · UNIVERSITY OF WASHINGTON · PI FANG, FERRIC C · 2003 to 2019
$2.8M
Role of OxyR in P. aeruginosa Biofilm Resistance to H202R01GM069845 · NIGMS · UNIVERSITY OF CINCINNATI · PI HASSETT, DANIEL J. · 2004 to 2007
$1.2M
Antibiotic-mediated Adaptation of Pseudomonas aeruginosaK08AI066251 · NIAID · UNIVERSITY OF WASHINGTON · PI HOFFMAN, LUCAS R. · 2005 to 2007
$379k
NIAID NIH HHS 1KO8AI066251NIAID NIH HHS K08 AI066251NIAID NIH HHS R01 AI039557NIAID NIH HHS R01 AI39557NIAID NIH HHS T32 AI055396NIAID NIH HHS T32 AI55396NIGMS NIH HHS GM-69845NIGMS NIH HHS R01 GM069845
6 · The paper itself

Abstract

Microbes are subjected to selective pressures during chronic infections of host tissues. Pseudomonas aeruginosa isolates with inactivating mutations in the transcriptional regulator LasR are frequently selected within the airways of people with cystic fibrosis (CF), and infection with these isolates has been associated with poorer lung function outcomes. The mechanisms underlying selection for lasR mutation are unknown but have been postulated to involve the abundance of specific nutrients within CF airway secretions. We characterized lasR mutant P. aeruginosa strains and isolates to identify conditions found in CF airways that select for growth of lasR mutants. Relative to wild-type P. aeruginosa, lasR mutants exhibited a dramatic metabolic shift, including decreased oxygen consumption and increased nitrate utilization, that is predicted to confer increased fitness within the nutrient conditions known to occur in CF airways. This metabolic shift exhibited by lasR mutants conferred resistance to two antibiotics used frequently in CF care, tobramycin and ciprofloxacin, even under oxygen-dependent growth conditions, yet selection for these mutants in vitro did not require preceding antibiotic exposure. The selection for loss of LasR function in vivo, and the associated adverse clinical impact, could be due to increased bacterial growth in the oxygen-poor and nitrate-rich CF airway, and from the resulting resistance to therapeutic antibiotics. The metabolic similarities among diverse chronic infection-adapted bacteria suggest a common mode of adaptation and antibiotic resistance during chronic infection that is primarily driven by bacterial metabolic shifts in response to nutrient availability within host tissues.

Indexed as

Adaptation, PhysiologicalBacterial ProteinsCystic FibrosisDrug Resistance, MicrobialFoodHumansLungMutationPseudomonas aeruginosaPseudomonas InfectionsReactive Nitrogen SpeciesSelection, GeneticTrans-ActivatorsBacterial ProteinsLasR protein, Pseudomonas aeruginosaReactive Nitrogen SpeciesTrans-Activators

Identifiers

PMID20072604
PMCPMC2795201
OpenAlexW2069717071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.